Renal expression of cytokines and chemokines in diabetic nephropathy
Authors:
- Liliane Silvano AraújoLALiliane Silvano Araújo
- Bianca Gonçalves Silva TorquatoBTBianca Gonçalves Silva Torquato
- Crislaine Aparecida da SilvaCSCrislaine Aparecida da Silva
- Maria Luíza Gonçalves dos Reis MonteiroMMMaria Luíza Gonçalves dos Reis Monteiro
- Ana Luisa Monteiro dos Santos MartinsAMAna Luisa Monteiro dos Santos Martins
- Marcos Vinícius da SilvaMarcos Vinícius da Silva
- Marlene Antônia dos ReisMRMarlene Antônia dos Reis
- Juliana Reis MachadoJMJuliana Reis Machado
Open Access
- 28 July 2020
- journal article
- research article
- Published by Springer Nature in BMC Nephrology
- Vol. 21 (1) , 1-11
Abstract
Background: Diabetic nephropathy (DN) is the leading cause of end-stage renal disease worldwide. Inflammatory mediators have been implicated in the pathogenesis of DN, thus considered an inflammatory disease. However, further studies are required to assess the renal damage caused by the action of these molecules. Therefore, the objective of this study was to analyze the expression of cytokines and chemokines in renal biopsies from patients with DN and to correlate it with interstitial inflammation and decreased renal function.Methods: Forty-four native renal biopsies from patients with DN and 23 control cases were selected. In situ expression of eotaxin, MIP-1α (macrophage inflammatory protein-1α), IL-8 (interleukin-8), IL-4, IL-10, TNF-α (tumor necrosis factor-α), TNFR1 (tumor necrosis factor receptor-1), IL-1β, and IL-6 were evaluated by immunohistochemistry.Results: The DN group showed a significant increase in IL-6 (p < 0.0001), IL-1β (p < 0.0001), IL-4 (p < 0.0001) and eotaxin (p = 0.0012) expression, and a decrease in TNFR1 (p = 0.0107) and IL-8 (p = 0.0262) expression compared to the control group. However, there were no significant differences in IL-10 (p = 0.4951), TNF-α (p = 0.7534), and MIP-1α (p = 0.3816) expression among groups. Regarding interstitial inflammation, there was a significant increase in IL-6 in scores 0 and 1 compared to score 2 (p = 0.0035), in IL-10 in score 2 compared to score 0 (p = 0.0479), and in eotaxin in score 2 compared to scores 0 and 1 (p < 0.0001), whereas IL-8 (p = 0.0513) and MIP-1α (p = 0.1801) showed no significant differences. There was a tendency for negative correlation between eotaxin and estimated glomerular filtration rate (eGFR) (p = 0.0566).Conclusions: Our results indicated an increased in situ production of cytokines and chemokines in DN, including IL-6, IL-1β, IL-4, and eotaxin. It was observed that, possibly, eotaxin may have an important role in the progression of interstitial inflammation in DN and in eGFR decrease of these patients.Keywords
This publication has 57 references indexed in Scilit:
- Innate versus adaptive immunity in kidney immunopathologyBMC Nephrology, 2013
- Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 DiabetesJournal of the American Society of Nephrology, 2012
- The Renal Mononuclear Phagocytic SystemJournal of the American Society of Nephrology, 2012
- Structural damage in diabetic nephropathy is associated with TNF-α system activityActa Diabetologica, 2011
- Role of T Cells in Type 2 Diabetic NephropathyExperimental Diabetes Research, 2011
- MULTIPLEX BEAD ANALYSIS OF URINARY CYTOKINES OF TYPE 2 DIABETIC PATIENTS WITH NORMO- AND MICROALBUMINURIAJournal of Immunoassay and Immunochemistry, 2010
- The Acute Effect of Clamped Hyperglycemia on the Urinary Excretion of Inflammatory Cytokines/Chemokines in Uncomplicated Type 1 DiabetesDiabetes Care, 2010
- Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathyClinica Chimica Acta, 2010
- The Role of Inflammatory Cytokines in Diabetic NephropathyJournal of the American Society of Nephrology, 2008
- Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathyClinical and Experimental Immunology, 2007